Skip to main content
Livermore
Livermore
ZHEN

MapLight Therapeutics, Inc.

MPLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001770069

In the last 90 days, MapLight Therapeutics, Inc. insiders filed 3 open-market purchases and 8 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $941.0M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding MapLight Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of MPLT: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders074+74
Shares023.1M+23.1M
Value$0$405.1M+$405.1M

New holders (74)

Institutions that held MapLight Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to MPLT in Q4 2025
InstitutionSharesValue% of portfolio
Novo Holdings A/S3,686,622$64.8M5.03%
FCPM III Services B.V.3,226,400$56.7M7.43%
T. Rowe Price Investment Management, Inc.2,799,180$49.2M0.03%
Goldman Sachs Group Inc1,937,168$34.0M0.00%
BlackRock, Inc.1,095,514$19.2M0.00%
Nan Fung Group Holdings Ltd971,253$17.1M15.27%
5AM Venture Management, LLC950,011$16.7M5.25%
Sanofi912,041$16.0M5.16%
Vanguard Group Inc869,668$15.3M0.00%
Pivotal bioVenture Partners Investment Advisor LLC611,447$10.7M4.15%
Perceptive Advisors LLC550,000$9.66M0.18%
Velan Capital Investment Management LP522,305$9.17M5.34%
Siren, L.L.C.450,000$7.90M0.24%
Geode Capital Management, LLC389,026$6.83M0.00%
Vestal Point Capital, LP385,000$6.76M0.25%
Baker Bros. Advisors LP364,705$6.41M0.04%
Jain Global LLC327,693$5.76M0.06%
Blue Owl Capital Holdings LP327,058$5.74M1.77%
State Street Corp229,484$4.03M0.00%
Lazard Asset Management LLC207,494$3.64M0.01%
Board of Trustees of The Leland Stanford Junior University199,233$3.50M0.71%
Citadel Advisors LLC190,139$3.34M0.00%
Freestone Grove Partners LP183,771$3.23M0.02%
Polygon Management Ltd.164,525$2.89M0.61%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.147,930$2.60M0.00%
DAFNA Capital Management LLC143,764$2.53M0.59%
Charles Schwab Investment Management Inc138,427$2.43M0.00%
Northern Trust Corp119,557$2.10M0.00%
Seven Grand Managers, LLC100,000$1.76M0.13%
StemPoint Capital LP100,000$1.76M0.30%
Burkehill Global Management, LP75,000$1.32M0.09%
Ameriprise Financial Inc66,872$1.17M0.00%
Diadema Partners LP63,791$1.12M0.67%
OrbiMed Advisors LLC56,000$952.0K0.02%
Tudor Investment Corp Et Al47,840$840.3K0.00%
Marshall Wace, LLP39,659$696.8K0.00%
Bank of America Corp37,820$664.3K0.00%
TD Asset Management Inc36,960$649.2K0.00%
Bank of New York Mellon Corp35,857$629.8K0.00%
Barclays PLC26,415$464.0K0.00%
Morgan Stanley23,222$407.9K0.00%
Persistent Asset Partners Ltd21,766$382.3K0.18%
Nuveen, LLC20,197$354.8K0.00%
Ghisallo Capital Management LLC20,000$351.3K0.02%
Wells Fargo & Company18,687$328.2K0.00%
UBS Group AG18,290$321.3K0.00%
Oxford Asset Management LLP17,763$312.0K0.11%
Millennium Management LLC13,945$244.9K0.00%
Rhumbline Advisers13,642$239.6K0.00%
Lynx1 Capital Management LP13,477$236.7K0.05%
Invesco Ltd.12,970$227.8K0.00%
Deutsche Bank AG11,928$209.6K0.00%
Walleye Capital LLC11,686$205.3K0.00%
LMR Partners LLP10,000$175.7K0.00%
MetLife Investment Management9,798$172.1K0.00%
Mirae Asset Global ETFs Holdings Ltd.7,815$137.3K0.00%
JPMorgan Chase & Co6,743$118.4K0.00%
New York State Common Retirement Fund5,300$93.1K0.00%
Police & Firemen's Retirement System of New Jersey3,986$70.0K0.00%
BNP Paribas Arbitrage, SA3,455$60.7K0.00%
STRS Ohio3,000$52.7K0.00%
Tower Research Capital LLC (TRC)2,870$50.4K0.00%
Legal & General Group Plc1,649$29.0K0.00%
Ameritas Investment Partners, Inc.1,371$24.1K0.00%
Russell Investments Group, Ltd.1,337$23.5K0.00%
California State Teachers Retirement System1,040$18.3K0.00%
FMR LLC904$15.9K0.00%
SBI Securities Co., Ltd.607$10.7K0.00%
Royal Bank of Canada582$10.0K0.00%
Sterling Capital Management LLC519$9.12K0.00%
Amalgamated Bank530$9.00K0.00%
Federation des caisses Desjardins du Quebec500$8.78K0.00%
Citigroup Inc383$6.73K0.00%
Farther Finance Advisors, LLC120$2.11K0.00%

Sold out (0)

Institutions that held MapLight Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

None.